Caribou Biosciences
Quarterly Financials
| Values in thousands | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
|---|---|---|---|---|
Revenue | $1,607 | $1,499 | $2,397 | $3,941 |
Gross Profit | 1,499 | 1,748 | 3,941 | |
EBITDA | -27,642 | -25,771 | -24,436 | -26,356 |
EBIT | -27,642 | -26,396 | -25,085 | -27,038 |
Net Income | -26,612 | -24,282 | -25,085 | -26,488 |
Net Change In Cash | 1,607 | 1,499 | 2,397 | 3,941 |
Free Cash Flow | -22,537 | -22,788 | -27,056 | -20,608 |
Cash | 26,057 | 26,194 | 12,057 | 12,360 |
Basic Shares | 107,535 | 100,985 | 95,861 | 94,536 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $11,159 | $9,994 | $34,477 | $13,851 |
Gross Profit | 7,514 | 6,067 | 30,952 | 10,210 |
EBITDA | -145,030 | -145,187 | -98,352 | -97,729 |
EBIT | -148,675 | -149,114 | -101,877 | -99,351 |
Net Income | -148,125 | -149,105 | -102,070 | -99,421 |
Net Change In Cash | 11,159 | 9,994 | 34,477 | 13,851 |
Cost of Revenue | -182,082 | |||
Free Cash Flow | -112,351 | -144,705 | -104,904 | -98,020 |
Cash | 12,360 | 16,293 | 51,162 | 58,338 |
Basic Shares | 93,389 | 90,317 | 73,807 | 60,801 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-09-30 | -$0.25 |
2026-06-30 | -$0.24 |
2026-03-31 | -$0.26 |
2025-12-31 | -$0.28 |